Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Hai, Chi Ming ^a   Sadowska, Grazyna ^a   Francois, Louise ^a   Stonestreet, Barbara S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Development; Glucocorticoid; Hypertension; Programming

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; MYOSIN LIGHT CHAIN; PHENYLEPHRINE; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; FETUS CIRCULATION; FETUS DEVELOPMENT; HYPERTENSION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; STEROID THERAPY; VASCULAR SMOOTH MUSCLE;

EID: 0036839105     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00281.2002     Document Type: Article

References (40)

1. Anwar MA, Schwab M, Poston L, and Nathanielsz PW. Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus. Am J Physiol Heart Circ Physiol 276: H1137-H1143, 1999.
2. Arens YHJM, Rosenfeld CR, and Kamm KE. Maturational differences between vascular and bladder smooth muscle during ovine development. Am J Physiol Regul Integr Comp Physiol 278: R1305-R1313, 2000.
3. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, and Ballard RA. Multiple courses of antenatal corticosteroids and outcome of premature neonates North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181: 709-717, 1999.
4. Berry LM, Polk DH, Ikegami M, Jobe AH, Padbury JF, and Ervin MG. Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol Regul Integr Comp Physiol 272: R1972-R1979, 1997.
5. 2- channels in fetal and adult ovine cerebral arteries. Am J Physiol Regul Integr Comp Physiol 282: R131-R138, 2002.
6. Cowett RM, Czech MP, Susa JB, Schwartz R, and Oh W. Blunted muscle responsiveness to insulin in the neonatal rat. Metabolism 29: 563-567, 1980.
7. Crowley P, Chalmers I, and Keirse MJ. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 97: 11-25, 1990.
8. Derks JB, Giussani DA, Jenkins SL, Wentworth RA, Visser GH, Padbury JF, and Nathanielsz PW. A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol 499: 217-226, 1997.
9. Docherty CC, Kalmar-Nagy J, Engelen M, and Nathanielsz PW. Development of fetal vascular responses to endothelin-1 and acetylcholine in the sheep. Am J Physiol Regul Integr Comp Physiol 280: R554-R562, 2001.
10. Dodic M, Baird R, Hantzis V, Kouokoulas I, Moritz K, Peers A, and Wintour EM. Organs/systems potentially involved in one model of programmed hypertension in sheep. Clin Exp Pharmacol Physiol 28: 952-956, 2001.
11. Eddinger TJ, Korwek AA, Meer DP, and Sherwood JJ. Expression of smooth muscle myosin light chain 17 and unloaded shortening in single smooth muscle cells. Am J Physiol Cell Physiol 278: C1133-C1142, 2000.
12. Eddinger TJ and Meer DP. Smooth muscle heterogeneity: Does the striated muscle model apply? Can J Physiol Pharmacol 75: 861-868, 1997.
13. Fisher SA, Ikebe M, and Brozovich F. Endothelin-1 alters the contractile phenotype of cultured embryonic smooth muscle cells. Circ Res 80: 885-893, 1997.
14. French NP, Hagan R, Evans SF, Godfrey M, and Newnham JP. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 180: 114-121, 1999.
15. 2-, crossbridge phosphorylation, and contraction. Annu Rev Physiol 51: 285-298, 1989.
16. Hai CM, Watson C, Wallach SJ, Reyes V, Kim E, and Xu J. Effects of substrate and inhibition of oxidative metabolism on contraction and myosin phosphorylation in ASM. Am J Physiol Lung Cell Mol Physiol 264: L553-L559, 1993.
17. Hegarty BD, Burrell JH, Gibson KJ, McMullen JR, and Lumbers ER. Effect of cortisol on fetal ovine vascular angiotensin II receptors and contractility. Eur J Pharmacol 406: 439-448, 2000.
18. Helper DJ, Lash JA, and Hathaway DR. Distribution of isoelectric variants of the 17,000-dalton myosin light chain in mammalian smooth muscle. J Biol Chem 263: 15748-15753, 1988.
19. 2+ homeostasis in vascular smooth muscle. J Vasc Res 32: 207-219, 1995.
20. Huang QQ, Fisher SA, and Brozovich FV. Forced expression of essential myosin light chain isoforms demonstrates their role in smooth muscle force production. J Biol Chem 274: 35095-35098, 1999.
21. Jobe AH, Wada N, Berry LM, Ikegami M, and Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 178: 880-885, 1998.
22. Langley-Evans SC. Intrauterine programming of hypertension by glucocorticoids. Life Sci 60: 1213-1221, 1997.
23. 2+ stores and contractility: changes with development. Am J Physiol Regul Integr Comp Physiol 279: R860-R873, 2000.
24. 2+]i and tension in fetal and adult cerebral arteries. Am J Physiol Regul Integr Comp Physiol 277: R286-R294, 1999.
25. Malmqvist U and Arner A. Correlation between isoform composition of the 17 kDaa myosin light chain and maximal shortening velocity in smooth muscle. Pflügers Arch 418: 523-530, 1991.
26. 1-Adrenoceptor-mediated phosphorylation of myosin in rat-tail arterial smooth muscle. Biochem J 327: 669-674, 1997.
27. Murphy RA, Walker JS, and Strauss JD. Myosin isoforms and functional diversity in vertebrate smooth muscle. Comp Biochem Physiol B Biochem Mol Biol 117: 51-60, 1997.
28. Nabeshima Y, Nonomura Y, and Fujii-Kuriyama Y. Nonmuscle and smooth muscle myosin light chain mRNAs are generated from a single gene by the tissue-specific alternative RNA splicing. J Biol Chem 262: 10608-10612, 1987.
29. National Institutes of Health Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes National Institutes of Health consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 273: 413-418, 1995.
30. Newnham JP. Is prenatal glucocorticoid administration another origin of adult disease? Clin Exp Pharmacol Physiol 28: 957-961, 2001.
31. Ogut O and Brozovich FV. Determinants of the contractile properties in the embryonic chicken gizzard and aorta. Am J Physiol Cell Physiol 279: C1722-C1732, 2000.
32. Okah FA, Pickens WL, and Hoath SB. Effect of prenatal steroids on skin surface hydrophobicity in the premature rat. Pediatr Res 37: 402-408, 1995.
33. Owen MP, Joyce EH, and Bevan JA. Sources of activator calcium for extrinsic vascular tone and nimodipine inhibition of that tone in proximal vs. distal rabbit ear arteries. J Pharmacol Exp Ther 243: 27-34, 1987.
34. Padbury JF, Polk DH, Ervin MG, Berry LM, Ikegami M, and Jobe AH. Postnatal cardiovascular and metabolic responses to a single intramuscular dose of betamethasone in fetal sheep born prematurely by cesarean section. Pediatr Res 38: 709-715, 1995.
35. Rayment I, Rypniewski WR, Schmidyt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, and Holden HM. Three-dimensional structure of myosin subfragment-1: A molecular motor. Science 261: 50-58, 1993.
36. Sartore S, Chiavegato A, Franch R, Faggin E, and Pauletto P. Myosin gene expression and cell phenotypes in vascular smooth muscle during development in experimental models, and in vascular disease. Arterioscler Thromb Vasc Biol 17: 1210-1215, 1997.
37. Stonestreet BS, Le E, and Berard DJ. Circulatory and metabolic effects of α-adrenergic blockade in the hyperinsulinemic ovine fetus. Am J Physiol Heart Circ Physiol 265: H1098-H1106, 1993.
38. Stonestreet BS, Patlak CS, Pettigrew KD, Reilly CB, and Cserr HF. Ontogeny of blood-brain barrier function in ovine fetuses, lambs, and adults. Am J Physiol Regul Integr Comp Physiol 271: R1594-R1601, 1996.
39. Stonestreet BS, Sadowska GB, McKnight AJ, Patlak C, and Petersson KH. Exogenous and endogenous corticosteroids modulate blood-brain barrier development in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 279: R468-R477, 2000.
40. Youn T, Kim SA, and Hai CM. Length-dependent modulation of smooth muscle activation: effects of agonist, cytochalasin, and temperature. Am J Physiol Cell Physiol 274: C1601-C1607, 1998.